Fundraising FoxPrimeGen Biotech
Santa Ana, US · Delaware LLC
Find your way into PrimeGen Biotech
Sign up to see every warm intro you have to PrimeGen Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PrimeGen Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TC
Thomas C.K. YuenManager and Chief Executive Officer
Board
SD
Steven D. GershickManager
WS
Wai SzetoManager
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 6 rounds · 2014–2016
▶$400KraisedAug 2016 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedAug 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven D. GershickDirector
- Thomas C.K. YuenExecutive Officer, Director
- Lenard MakowkaDirector
- Wai Sun SzetoDirector
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Jul 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedMay 2016 · 1 investors · BiotechnologyRule 506(b)
▶$1.7MraisedMay 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wai Sun SzetoDirector
- Lenard MakowkaDirector
- Thomas C.K. YuenExecutive Officer, Director
- Steven D. GershickDirector
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1MraisedJan 2016 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedJan 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wai Sun SzetoDirector
- Steven D. GershickDirector
- Thomas C.K. YuenExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$450KraisedJul 2015 · 1 investors · BiotechnologyRule 506(b)
▶$450KraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas C.K. YuenExecutive Officer, Director
- Steven D. GershickDirector
- Wai SzetoDirector
- Offering amount
- $450K
- Amount sold
- $450K
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJul 2015 · 1 investors · BiotechnologyRule 506(b)
▶$1.4MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven D. GershickDirector
- Wai SzetoDirector
- Thomas C.K. YuenExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Apr 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$17.6MraisedAug 2014 · 2 investors · OtherRule 506(b)
▶$17.6MraisedAug 2014 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas C.K. YuenExecutive Officer, Director
- Wai SzetoDirector
- Steven GershickDirector
- Offering amount
- $17.6M
- Amount sold
- $17.6M
- First sale
- Aug 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has PrimeGen Biotech raised?
- PrimeGen Biotech has disclosed $22.5M raised across 6 rounds.
- Where is PrimeGen Biotech headquartered?
- PrimeGen Biotech is headquartered in Santa Ana, US.